System for making dried singulated crosslinked cellulose pulp fibers

Details for Australian Patent Application No. 2003200035 (hide)

Owner Weyerhaeuser Company

Inventors Vrbanac, Michael David; Wester, Brian; Dezutter, Ramon Charles; Yancey, Michael James

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003200035

Priority 10/051,392 16.01.02 US

Parent 2002300959

Filing date 7 January 2003

Wipo publication date 31 July 2003

Acceptance publication date 14 February 2008

International Classifications

D21C 9/18 (2006.01) After-treatment of cellulose pulp, e.g. of wood pulp, or cotton linters

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 10/051,392 16.01.02 US

31 July 2003 Application Open to Public Inspection

  Published as AU-B-2003200035

5 January 2006 Amendment Made

  The nature of the amendment is: Add priority details 2002300959 09 Sept 2002 AU 2003206888 SAP AG The nature of the amendment is: Amend the name of the applicant from SAP Aktiengesellschaft to SAP AG

14 February 2008 Application Accepted

  Published as AU-B-2003200035

12 June 2008 Standard Patent Sealed

2 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003200036-Dried singulated crosslinked cellulose pulp fibers

2003200034-New derivatives of octahydro-6, 10-dioxo-6H-pyridazino [1,2-A][1,2]diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds